|
US9006175B2
(en)
|
1999-06-29 |
2015-04-14 |
Mannkind Corporation |
Potentiation of glucose elimination
|
|
US6923175B2
(en)
|
2002-03-20 |
2005-08-02 |
Mannkind Corporation |
Inhalation apparatus
|
|
CN101010305B
(zh)
|
2004-08-20 |
2010-08-11 |
曼金德公司 |
二酮哌嗪合成的催化反应
|
|
BR122019022692B1
(pt)
|
2004-08-23 |
2023-01-10 |
Mannkind Corporation |
Composição terapêutica em pó seco contendo dicetopiperazina, pelo menos um tipo de cátion e um agente biologicamente ativo
|
|
KR101384456B1
(ko)
|
2005-09-14 |
2014-04-10 |
맨카인드 코포레이션 |
활성제에 대한 결정질 미립자 표면의 친화력의 증가를 기반으로 하는 약물 제제화의 방법
|
|
US8497258B2
(en)
|
2005-11-12 |
2013-07-30 |
The Regents Of The University Of California |
Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
|
|
AU2006335994A1
(en)
|
2006-01-19 |
2007-07-26 |
Optinose As |
Nasal administration
|
|
ES2647080T3
(es)
|
2006-02-22 |
2017-12-19 |
Mannkind Corporation |
Un método para mejorar las propiedades farmacéuticas de micropartículas que comprenden dicetopiperazina y un agente activo
|
|
US8614236B2
(en)
*
|
2006-12-12 |
2013-12-24 |
University Of Washington |
Methods of treating pulmonary disease using acetazolamide and structurally related derivatives
|
|
GB2448183A
(en)
|
2007-04-05 |
2008-10-08 |
Optinose As |
Nasal powder delivery device
|
|
WO2011163272A1
(en)
|
2010-06-21 |
2011-12-29 |
Mannkind Corporation |
Dry powder drug delivery system and methods
|
|
US20100216754A1
(en)
*
|
2007-11-13 |
2010-08-26 |
Meritage Pharma, Inc. |
Compositions for the treatment of inflammation of the gastrointestinal tract
|
|
LT3354276T
(lt)
|
2007-11-13 |
2020-04-27 |
Meritage Pharma, Inc. |
Kompozicijos, skirtos skrandžio ir žarnyno uždegimo gydymui
|
|
US9050368B2
(en)
*
|
2007-11-13 |
2015-06-09 |
Meritage Pharma, Inc. |
Corticosteroid compositions
|
|
JP5570996B2
(ja)
|
2007-12-14 |
2014-08-13 |
エアロデザインズ インコーポレイテッド |
エアロゾル化可能な食料品の送達
|
|
JP5485879B2
(ja)
*
|
2008-05-15 |
2014-05-07 |
株式会社ココカラファインネクスト |
異なる物性の薬物の一剤形化
|
|
DK2293833T3
(en)
|
2008-06-13 |
2016-05-23 |
Mannkind Corp |
DRY POWDER INHALER AND MEDICINAL ADMINISTRATION SYSTEM
|
|
US8485180B2
(en)
|
2008-06-13 |
2013-07-16 |
Mannkind Corporation |
Dry powder drug delivery system
|
|
CA2728523C
(en)
|
2008-06-20 |
2020-03-10 |
Mannkind Corporation |
An interactive apparatus and method for real-time profiling of inhalation efforts
|
|
TWI532497B
(zh)
|
2008-08-11 |
2016-05-11 |
曼凱公司 |
超快起作用胰島素之用途
|
|
US8314106B2
(en)
|
2008-12-29 |
2012-11-20 |
Mannkind Corporation |
Substituted diketopiperazine analogs for use as drug delivery agents
|
|
CA2754595C
(en)
|
2009-03-11 |
2017-06-27 |
Mannkind Corporation |
Apparatus, system and method for measuring resistance of an inhaler
|
|
CA2835771C
(en)
*
|
2009-03-18 |
2017-01-24 |
Incarda Therapeutics, Inc. |
Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administration
|
|
US8551528B2
(en)
|
2009-06-12 |
2013-10-08 |
Mannkind Corporation |
Diketopiperazine microparticles with defined specific surface areas
|
|
JP5784622B2
(ja)
|
2009-11-03 |
2015-09-24 |
マンカインド コーポレ−ション |
吸入活動をシミュレートするための装置及び方法
|
|
RU2445119C2
(ru)
*
|
2010-05-25 |
2012-03-20 |
Сергей Викторович Чепур |
Фармацевтическая композиция и способ ее ингаляционного введения
|
|
CN107096014B
(zh)
|
2010-09-29 |
2022-07-15 |
普马特里克斯营业公司 |
吸入用单价金属阳离子干粉剂
|
|
GB2488992A
(en)
*
|
2011-03-10 |
2012-09-19 |
Advanced Ophthalmic Pharma Ltd |
Medicament dispenser
|
|
ES2625858T3
(es)
|
2011-04-01 |
2017-07-20 |
Mannkind Corporation |
Paquete de tipo blíster para cartuchos farmacéuticos
|
|
HRP20161757T1
(hr)
*
|
2011-05-03 |
2017-02-10 |
Chiesi Farmaceutici S.P.A. |
Poboljšana formulacija suspenzije beklometazon-dipropionata za davanje inhalacijom
|
|
WO2012174472A1
(en)
|
2011-06-17 |
2012-12-20 |
Mannkind Corporation |
High capacity diketopiperazine microparticles
|
|
HK1201475A1
(en)
|
2011-10-24 |
2015-09-04 |
Mannkind Corporation |
Methods and compositions for treating pain
|
|
CA3098386C
(en)
|
2012-07-12 |
2022-11-29 |
Mannkind Corporation |
Dry powder drug delivery systems and methods
|
|
JP6197515B2
(ja)
*
|
2012-10-19 |
2017-09-20 |
大正製薬株式会社 |
医薬組成物
|
|
EP2911690A1
(en)
|
2012-10-26 |
2015-09-02 |
MannKind Corporation |
Inhalable influenza vaccine compositions and methods
|
|
US9757395B2
(en)
|
2012-12-20 |
2017-09-12 |
Otitopic Inc. |
Dry powder inhaler and methods of use
|
|
US9757529B2
(en)
|
2012-12-20 |
2017-09-12 |
Otitopic Inc. |
Dry powder inhaler and methods of use
|
|
KR20180092324A
(ko)
|
2013-03-13 |
2018-08-20 |
포레스트 래보러토리즈 홀딩스 리미티드 |
미분화된 약제학적 조성물
|
|
US9452139B2
(en)
|
2013-03-14 |
2016-09-27 |
Novartis Ag |
Respirable agglomerates of porous carrier particles and micronized drug
|
|
MX369136B
(es)
|
2013-03-15 |
2019-10-30 |
Mannkind Corp |
Composiciones de dicetopiperazina microcristalina y metodos.
|
|
US11554229B2
(en)
|
2013-03-26 |
2023-01-17 |
OptiNose Inc. |
Nasal administration
|
|
ITMI20130571A1
(it)
*
|
2013-04-10 |
2014-10-11 |
Zambon Spa |
Composizione farmaceutica contenente budesonide e formoterolo
|
|
ITMI20130572A1
(it)
*
|
2013-04-10 |
2014-10-11 |
Eratech Srl |
Composizione comprendente almeno due polveri secche ottenute per spray dry per aumentare la stabilita' della formulazione
|
|
US10149823B2
(en)
|
2013-04-30 |
2018-12-11 |
Otitopic Inc. |
Dry powder formulations and methods of use
|
|
WO2016004409A1
(en)
*
|
2014-07-03 |
2016-01-07 |
Luxena Pharmaceuticals, Inc. |
Novel aerosol formulations of ondansetron and uses thereof
|
|
CN104274426A
(zh)
|
2013-07-03 |
2015-01-14 |
陆克塞纳医药公司 |
昂丹司琼细粉、昂丹司琼气溶胶组合物及其用途
|
|
BR122019026637B1
(pt)
|
2013-07-18 |
2023-09-26 |
Mannkind Corporation |
Formulações farmacêuticas de pó seco e método para a fabricação de uma formulação de pó seco
|
|
US11446127B2
(en)
|
2013-08-05 |
2022-09-20 |
Mannkind Corporation |
Insufflation apparatus and methods
|
|
RU2539374C1
(ru)
*
|
2013-11-29 |
2015-01-20 |
Федеральное государственное автономное образовательное учреждение высшего образования "Новосибирский национальный исследовательский государственный университет" (Новосибирский государственный университет, НГУ) |
Высокодисперсная комбинированная фармацевтическая композиция беклометазона и сальбутамола с бета-глицином и способ ее получения
|
|
GB201321712D0
(en)
*
|
2013-12-09 |
2014-01-22 |
Pharmachemie Bv |
Dry Powder Inhaler
|
|
CN112656780A
(zh)
|
2014-02-20 |
2021-04-16 |
奥迪托皮克股份有限公司 |
用于吸入的干粉制剂
|
|
WO2015148905A1
(en)
|
2014-03-28 |
2015-10-01 |
Mannkind Corporation |
Use of ultrarapid acting insulin
|
|
WO2015187356A1
(en)
*
|
2014-06-04 |
2015-12-10 |
Quick Joshua Ryan |
System and method for delivering an inhalable sugar formulation
|
|
RU2699995C2
(ru)
|
2014-09-15 |
2019-09-12 |
ВЕРОНА ФАРМА ПиэЛСи |
Жидкая ингаляционная композиция, содержащая rpl 554
|
|
US10561806B2
(en)
|
2014-10-02 |
2020-02-18 |
Mannkind Corporation |
Mouthpiece cover for an inhaler
|
|
KR102462058B1
(ko)
|
2014-10-08 |
2022-11-01 |
잠본쏘시에떼퍼아찌오니 |
제제의 안정성을 증가시키기 위해 분무 건조에 의해 수득된 1종 이상의 건조 분말을 포함하는 조성물
|
|
MX372705B
(es)
*
|
2014-10-08 |
2020-06-18 |
Zambon Spa |
Composición farmacéutica que contiene budesonida y formoterol
|
|
CN107106641B
(zh)
|
2014-10-31 |
2021-12-21 |
葛兰素史密斯克莱知识产权发展有限公司 |
粉末制剂
|
|
WO2017022814A1
(ja)
*
|
2015-08-05 |
2017-02-09 |
第一三共株式会社 |
ネブライザー用組成物
|
|
EP3346987A1
(en)
*
|
2015-09-09 |
2018-07-18 |
Novartis AG |
Targeted delivery of spray-dried formulations to the lungs
|
|
CN118078742A
(zh)
|
2015-10-20 |
2024-05-28 |
斯帕方有限公司 |
包含丹曲林的水性组合物
|
|
CN109069495A
(zh)
|
2016-02-01 |
2018-12-21 |
英凯达治疗公司 |
电子监测联合吸入药理学疗法管理包括心房颤动在内的心律失常
|
|
CN109310622A
(zh)
*
|
2016-06-30 |
2019-02-05 |
菲利普莫里斯生产公司 |
尼古丁颗粒和组合物
|
|
ES3005760T3
(en)
*
|
2016-06-30 |
2025-03-17 |
Philip Morris Products Sa |
Nicotine particles
|
|
RU2766086C2
(ru)
|
2016-10-14 |
2022-02-07 |
Пулматрикс Оперэйтинг Компани, Инк. |
Противогрибковые сухие порошки
|
|
RU2770039C2
(ru)
*
|
2017-03-07 |
2022-04-14 |
Филип Моррис Продактс С.А. |
Вдыхаемые составы на основе никотина и способы их получения и применения
|
|
CN110869018A
(zh)
|
2017-05-10 |
2020-03-06 |
英凯达治疗公司 |
通过肺部施用治疗心脏病况的单位剂量、气雾剂、试剂盒和方法
|
|
AU2018318123B2
(en)
|
2017-08-15 |
2024-07-25 |
Nephron Pharmaceuticals Corporation |
Aqueous nebulization composition
|
|
AU2017432640B2
(en)
|
2017-09-22 |
2023-11-30 |
Aspeya US Inc. |
Dry powder compositions with magnesium stearate
|
|
US10786456B2
(en)
|
2017-09-22 |
2020-09-29 |
Otitopic Inc. |
Inhaled aspirin and magnesium to treat inflammation
|
|
US11278492B2
(en)
|
2018-01-05 |
2022-03-22 |
Impel Neuropharma, Inc. |
Intranasal delivery of olanzapine by precision olfactory device
|
|
WO2019183470A2
(en)
|
2018-03-22 |
2019-09-26 |
Incarda Therapeutics, Inc. |
A novel method to slow ventricular rate
|
|
WO2020150460A1
(en)
*
|
2019-01-18 |
2020-07-23 |
Milne Iii Donald A |
Micronized aspirin formulation
|
|
US11007185B2
(en)
|
2019-08-01 |
2021-05-18 |
Incarda Therapeutics, Inc. |
Antiarrhythmic formulation
|
|
RU2730488C1
(ru)
*
|
2019-08-20 |
2020-08-24 |
Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт биомедицинской химии имени В.Н. Ореховича" (ИБМХ) |
Фармацевтическая композиция на основе глюкокортикостероида будесонида и фосфатидилхолина для сухой ингаляции
|
|
GB201914532D0
(en)
*
|
2019-10-08 |
2019-11-20 |
Univ Of Huddersfield |
Lactose particles and method of production thereof
|
|
RU2735502C1
(ru)
*
|
2020-01-09 |
2020-11-03 |
Федеральное государственное бюджетное учреждение науки Удмуртский федеральный исследовательский центр Уральского отделения Российской академии наук |
Аэрозоль для ингаляций при обструктивном бронхите
|
|
CN111202723A
(zh)
*
|
2020-02-15 |
2020-05-29 |
江苏艾立康药业股份有限公司 |
一种达芦那韦吸入干粉药物组合物及其制备方法
|
|
MX2023001201A
(es)
*
|
2020-07-31 |
2023-05-03 |
Chemo Res S L |
Terapia combinada para la administracion por inhalacion.
|
|
US20250108068A1
(en)
*
|
2023-09-28 |
2025-04-03 |
Color Ventures LLC |
Compositions and methods for alleviating pulmonary ailments
|